{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:55:51Z","timestamp":1793717751408,"version":"4.6.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijbiomac.2026.152333","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:03:35Z","timestamp":1777590215000},"page":"152333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Alginate-functionalized and PEGylated niosomes co-encapsulating letrozole and berberine for preclinical breast cancer therapy: Overcoming multidrug resistance"],"prefix":"10.1016","volume":"364","author":[{"given":"Zahra","family":"Velashjerdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossien","family":"Ghafouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Noorbazargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152333_bb0005","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.5888\/pcd18.210006","article-title":"Cancer incidence projections in the United States between 2015 and 2050","volume":"18","author":"Weir","year":"2021","journal-title":"Prev. Chronic Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152333_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cyto.a.20018","article-title":"Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin","volume":"58","author":"Huang","year":"2004","journal-title":"Cytometry A"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152333_bb0015","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/molecules27061794","article-title":"Genesis and mechanism of some cancer types and an overview on the role of diet and nutrition in cancer prevention","volume":"27","author":"Kamal","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.omega.2018.09.009","article-title":"A partially observable Markov chain framework to estimate overdiagnosis risk in breast cancer screening: incorporating uncertainty in patients adherence behaviors","volume":"89","author":"Molani","year":"2019","journal-title":"Omega"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152333_bb0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0002-9378(86)90623-X","article-title":"Ovarian cancer in the elderly: an analysis of surveillance, epidemiology, and end results program data","volume":"154","author":"Yancik","year":"1986","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.152333_bb0030","first-page":"3689","article-title":"The search for meaning\u2014symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy","volume":"115","author":"Pavlik","year":"2009","journal-title":"Cancer Interdiscipl. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopha.2017.08.045","article-title":"Berberine activates caspase-9\/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo","volume":"95","author":"Zhao","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.colsurfb.2012.09.019","article-title":"Doxorubicin loaded magneto-niosomes for targeted drug delivery","volume":"102","author":"Tavano","year":"2013","journal-title":"Colloid Surf. B-Biointerfaces"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152333_bb0045","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","article-title":"Hyaluronic acid-targeted niosomes for effective breast cancer chemostarvation therapy","volume":"9","author":"Kaveh Zenjanab","year":"2024","journal-title":"ACS Omega"},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.152333_bb0050","doi-asserted-by":"crossref","first-page":"9668","DOI":"10.3390\/ijms23179668","article-title":"Current advances in specialised niosomal drug delivery: manufacture, characterization and drug delivery applications","volume":"23","author":"Witika","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120380","article-title":"Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma","volume":"598","author":"Allam","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152333_bb0060","doi-asserted-by":"crossref","first-page":"e3070","DOI":"10.1038\/cddis.2017.471","article-title":"Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition","volume":"8","author":"Hou","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0065","article-title":"Effects of a cancer-associated mutation and multiple serine phosphorylation on poly (ADP-ribose) polymerase 2","volume":"2","author":"Hughes","year":"2025","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12645-024-00252-8","article-title":"Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy","volume":"15","author":"Safari Sharafshadeh","year":"2024","journal-title":"Cancer Nanotechnol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152333_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.61186\/JCT.15.4.299","article-title":"Synthesis and evaluation of physicochemical properties of a solid lipid Nanocarrier containing a sulfonamide derivative and investigation of its effect on breast Cancer cells","volume":"15","author":"Rahdari","year":"2024","journal-title":"Cell Tissue J."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/09603271251322531","article-title":"Enhancing breast cancer treatment: evaluating the efficacy of hyaluronic acid-coated tamoxifen-loaded solid lipid nanoparticles on MCF7 cells","volume":"44","author":"Ghayoumipour","year":"2025","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0085","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1038\/s41598-025-90107-y","article-title":"Advancing triple-negative breast cancer treatment through peptide decorated solid lipid nanoparticles for paclitaxel delivery","volume":"15","author":"Rahdari","year":"2025","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.152333_bb0090","doi-asserted-by":"crossref","first-page":"17310","DOI":"10.1021\/acsomega.4c10153","article-title":"Design and characterization of peptide-conjugated solid lipid nanoparticles for targeted MRI and SPECT imaging of breast tumors","volume":"10","author":"Rahdari","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0095","first-page":"100946","article-title":"Hyaluronic acid-coated magnetic solid lipid nanoparticles for cancer-targeted delivery of gemcitabine and imaging agent","volume":"11","author":"Motamedifar","year":"2025","journal-title":"Carbohydr. Polym. Technol. Appl."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0100","series-title":"Functionalized nanomaterials for cancer research","first-page":"37","article-title":"Cancer Nanotechnology: A New Approach to Upgrade cancer Diagnosis and Therapy","author":"Rad","year":"2024"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","article-title":"Nano-niosomes as nanoscale drug delivery systems: an illustrated review","volume":"185","author":"Moghassemi","year":"2014","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152333_bb0110","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1007\/s00210-023-02579-2","article-title":"Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer","volume":"396","author":"Asghari Lalami","year":"2023","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0351-4","article-title":"Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy","volume":"16","author":"Alemi","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152333_bb0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1039\/D2ME00024E","article-title":"Evaluation of anti-cancer and anti-metastatic effects of folate-PEGylated niosomes for co-delivery of letrozole and ascorbic acid on breast cancer cells","volume":"7","author":"Bourbour","year":"2022","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijbiomac.2014.12.052","article-title":"Calcium alginate-carboxymethyl cellulose beads for colon-targeted drug delivery","volume":"75","author":"Agarwal","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.152333_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0378-5173(01)00915-2","article-title":"Alginate\/chitosan particulate systems for sodium diclofenac release","volume":"232","author":"Gonz\u00e1lez-Rodr\u0131guez","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0135","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijbiomac.2015.09.052","article-title":"Development of liposomes entrapped in alginate beads for the treatment of colorectal cancer","volume":"82","author":"Bansal","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","article-title":"Alginate: properties and biomedical applications","volume":"37","author":"Lee","year":"2012","journal-title":"Prog. Polym. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.152333_bb0145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijpharm.2017.07.083","article-title":"Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus","volume":"530","author":"Maestrelli","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152333_bb0150","first-page":"513","article-title":"Chitosan\u2013sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation","volume":"68","author":"Motwani","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152333_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/biology10030173","article-title":"Preparation, optimization and in-vitro evaluation of curcumin-loaded niosome@ calcium alginate nanocarrier as a new approach for breast cancer treatment","volume":"10","author":"Akbarzadeh","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0160","article-title":"Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy","volume":"235","author":"Sharafshadeh","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0165","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.colsurfb.2012.09.039","article-title":"Coaxial electrospinning with acetic acid for preparing ferulic acid\/zein composite fibers with improved drug release profiles","volume":"102","author":"Yang","year":"2013","journal-title":"Colloid Surf. B-Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103371","article-title":"Characterization and optimization of co-delivery Farnesol-Gingerol Niosomal formulation to enhance anticancer activities against breast cancer cells","volume":"72","author":"Lalami","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0175","article-title":"Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer","volume":"16","author":"Mansoori-Kermani","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101854","article-title":"Development of trans-Ferulic acid niosome: an optimization and an in-vivo study","volume":"59","author":"Rezaeiroshan","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.917368","article-title":"Multifunctional PEGylated niosomal nanoparticle-loaded herbal drugs as a novel nano-radiosensitizer and stimuli-sensitive nanocarrier for synergistic cancer therapy","volume":"10","author":"Afereydoon","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152333_bb0190","doi-asserted-by":"crossref","first-page":"20168","DOI":"10.1007\/s11356-022-23507-6","article-title":"Biogenic synthesis of gold nanoparticles using Satureja rechingeri Jamzad: a potential anticancer agent against cisplatin-resistant A2780CP ovarian cancer cells","volume":"30","author":"Asl","year":"2023","journal-title":"Environ. Sci. Pollut. Res."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.152333_bb0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.152333_bb0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2015.03.020","article-title":"Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box\u2013Behnken design, in-vitro evaluation and in-vivo skin deposition study","volume":"485","author":"Abdelbary","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.colsurfb.2007.01.014","article-title":"Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release","volume":"58","author":"Bandyopadhyay","year":"2007","journal-title":"Colloid Surf. B-Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0210","series-title":"Nanostructures for drug delivery","first-page":"207","article-title":"Niosomes: A Novel Approach in Modern Drug Delivery Systems","author":"Khoee","year":"2017"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijbiomac.2016.01.013","article-title":"Chitosan gel-embedded moxifloxacin niosomes: an efficient antimicrobial hybrid system for burn infection","volume":"85","author":"Sohrabi","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152333_bb0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/2211738511666230607121118","article-title":"Characterization and in-vitro study of micro-encapsulation chitosan alginate of single-bulb garlic extract","volume":"12","author":"Lestari","year":"2024","journal-title":"J. Pharm. Nanotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152333_bb0225","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/jps.20491","article-title":"Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity","volume":"95","author":"Shi","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40005-017-0331-y","article-title":"Artemisinin-loaded niosome and pegylated niosome: physico-chemical characterization and effects on MCF-7 cell proliferation","volume":"48","author":"Asgharkhani","year":"2018","journal-title":"J. Pharm. Invest."},{"issue":"48","key":"10.1016\/j.ijbiomac.2026.152333_bb0235","doi-asserted-by":"crossref","first-page":"30008","DOI":"10.1039\/C7RA01736G","article-title":"Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers","volume":"7","author":"Naderinezhad","year":"2017","journal-title":"RSC Adv."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152333_bb0240","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/acsabm.1c01107","article-title":"pH-responsive, adorned nanoniosomes for codelivery of cisplatin and epirubicin: synergistic treatment of breast cancer","volume":"5","author":"Moammeri","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0245","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.2147\/IJN.S211844","article-title":"Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes","author":"Hemati","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152333_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18710","article-title":"Niosomes in cancer treatment: a focus on curcumin encapsulation","volume":"9","author":"Bashkeran","year":"2023","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152333_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.606","article-title":"Computationally guided design and synthesis of dual-drug loaded polymeric nanoparticles for combination therapy","volume":"5","author":"Jin","year":"2024","journal-title":"Aggregate"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0260","doi-asserted-by":"crossref","first-page":"27380","DOI":"10.1038\/s41598-024-78817-1","article-title":"Efficient PEGylated magnetic nanoniosomes for co-delivery of artemisinin and metformin: a new frontier in chemotherapeutic efficacy and cancer therapy","volume":"14","author":"Shahbazi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0265","article-title":"Formulation and evaluation of niosomal gel of antifungal Luliconazole","volume":"12","author":"Mishra","year":"2022","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101715","article-title":"Optimized doxycycline-loaded niosomal formulation for treatment of infection-associated prostate cancer: an in-vitro investigation","volume":"57","author":"Akbarzadeh","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110711","article-title":"Effect of drug molecular weight on niosomes size and encapsulation efficiency","volume":"186","author":"Garc\u00eda-Manrique","year":"2020","journal-title":"Colloid Surf. B-Biointerfaces"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1208\/s12249-022-02212-0","article-title":"The optimized formulation of tamoxifen-loaded niosomes efficiently induced apoptosis and cell cycle arrest in breast cancer cells","volume":"23","author":"Akbarzadeh","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152333_bb0285","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3390\/ph16081099","article-title":"Synergistic combination of Letrozole and Berberine in ascorbic acid-stabilized AuNPs: a promising solution for breast Cancer","volume":"16","author":"Foudah","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152333_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126821","article-title":"Synthesis and anticancer activity of novel 9, 13-disubstituted berberine derivatives","volume":"30","author":"Wang","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.152333_bb0295","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.3390\/molecules26237368","article-title":"Berberine as a potential anticancer agent: a comprehensive review","volume":"26","author":"Rauf","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152333_bb0300","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1007\/s11033-022-07199-2","article-title":"Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines","volume":"49","author":"Pourmoghadasiyan","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.152333_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175418","article-title":"pH-responsive PEGylated niosomal nanoparticles as an active-targeting cyclophosphamide delivery system for gastric cancer therapy","volume":"27","author":"Khodabakhsh","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120908","article-title":"Effect of nanovesicular surface-functionalization via chitosan and\/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model","volume":"307","author":"Megahed","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152333_bb0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/pharmaceutics16020223","article-title":"Niosomes: composition, formulation techniques, and recent progress as delivery systems in cancer therapy","volume":"16","author":"Liga","year":"2024","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152333_bb0320","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/0124681873335092250115022230","article-title":"Niosomes: a revolutionary approach for skin cancer treatment","volume":"15","author":"Padave","year":"2025","journal-title":"Curr. Nanomed."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152333_bb0325","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/molehr\/4.12.1099","article-title":"The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death","volume":"4","author":"Basu","year":"1998","journal-title":"Mol. Hum. Reprod."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3305","article-title":"The function of chitosan\/agarose biopolymer on Fe2O3 nanoparticles and evaluation of their effects on MCF-7 breast cancer cell line and expression of BCL2 and BAX genes","volume":"39","author":"Nouri Hajbaba","year":"2023","journal-title":"Biotechnol. Prog."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152333_bb0335","doi-asserted-by":"crossref","DOI":"10.4103\/2395-3977.177558","article-title":"BCL2 family, mitochondrial apoptosis, and beyond","volume":"2","author":"Dai","year":"2016","journal-title":"Cancer Transl. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152333_bb0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2009.05.015","article-title":"Molecular mechanisms involved in farnesol-induced apoptosis","volume":"287","author":"Joo","year":"2010","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152333_bb0345","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3109\/02652048.2013.788088","article-title":"Niosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistribution","volume":"30","author":"Sezgin-Bayindir","year":"2013","journal-title":"J. Microencapsul."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152333_bb0350","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jcb.22198","article-title":"The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells","volume":"107","author":"Hur","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152333_bb0355","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2174\/1871520619666190405111151","article-title":"Effects of resveratrol, berberine and their combinations on reactive oxygen species, survival and apoptosis in human squamous carcinoma (SCC-25) cells","volume":"19","author":"Skonieczna","year":"2019","journal-title":"Anti-Cancer Agents Med. Chem. Anti-Cancer Agents"},{"key":"10.1016\/j.ijbiomac.2026.152333_bb0360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2018.09.016","article-title":"VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC","volume":"129","author":"Zhou","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152333_bb0365","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.3892\/mmr.2014.3139","article-title":"Berberine inhibits the proliferation of prostate cancer cells and induces G0\/G1 or G2\/M phase arrest at different concentrations","volume":"11","author":"Lu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"S1","key":"10.1016\/j.ijbiomac.2026.152333_bb0370","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2018.32.1_supplement.804.5","article-title":"Effects of Vorinostat, Letrozole and RG7388 treatments on cell cycle arrest and survival of breast and prostate cancer cells","volume":"32","author":"Natarajan","year":"2018","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152333_bb0375","first-page":"6141","article-title":"Berberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis","volume":"37","author":"Du","year":"2017","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152333_bb0380","first-page":"1089","article-title":"Combination of berberine and matrine affects apoptosis and cellcycle in human cervical cancer cells","volume":"76","author":"Zhang","year":"2019","journal-title":"Acta Poloniae Pharm. Drug Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152333_bb0385","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.nano.2015.07.010","article-title":"In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells","volume":"11","author":"Dwivedi","year":"2015","journal-title":"Nanomedicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152333_bb0390","doi-asserted-by":"crossref","first-page":"183","DOI":"10.30699\/ijp.2022.124340.2358","article-title":"Apoptosis induction, cell cycle arrest and anti-cancer potential of tamoxifen-curcumin loaded niosomes against MCF-7 cancer cells","volume":"17","author":"Fatemizadeh","year":"2022","journal-title":"Iran. J. Pathol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026022609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:54:35Z","timestamp":1789998875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026022609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":78,"alternative-id":["S0141813026022609"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152333","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alginate-functionalized and PEGylated niosomes co-encapsulating letrozole and berberine for preclinical breast cancer therapy: Overcoming multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152333"}}